Page last updated: 2024-10-30

memantine and HIV

memantine has been researched along with HIV in 2 studies

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schifitto, G1
Yiannoutsos, CT1
Simpson, DM1
Marra, CM1
Singer, EJ1
Kolson, DL1
Nath, A1
Berger, JR1
Navia, B1
Kornhuber, J1
Bormann, J1

Trials

1 trial available for memantine and HIV

ArticleYear
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
    Journal of neurovirology, 2006, Volume: 12, Issue:4

    Topics: Adult; Excitatory Amino Acid Antagonists; Female; HIV; HIV Infections; Humans; Male; Memantine; Peri

2006

Other Studies

1 other study available for memantine and HIV

ArticleYear
Neuroprotective effects of memantine.
    Neurology, 1993, Volume: 43, Issue:5

    Topics: Animals; Dizocilpine Maleate; HIV; HIV Envelope Protein gp120; Memantine; N-Methylaspartate; Neurons

1993